FITC-abaloparatide

FITC-abaloparatide is a fluorescently labeled peptide enabling visualization of conformational changes and receptor interactions. The FITC moiety enhances optical detection without disrupting the core structural motifs. Researchers employ it in membrane-binding studies and kinetic fluorescence assays. Its dual composition supports advanced bioanalytical experimentation.

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.

CAT No: R1832

Synonyms/Alias:FITC-abaloparatide;BAT-006259

Custom Peptide Synthesis
cGMP Peptide
  • Registration of APIs
  • CMC information required for an IND
  • IND and NDA support
  • Drug master files (DMF) filing
Purity
> 95%

FITC-abaloparatide is a synthetic peptide derivative of abaloparatide, a selective analog of parathyroid hormone-related protein (PTHrP), that has been covalently conjugated to fluorescein isothiocyanate (FITC). This dual-functional molecule combines the receptor-binding and signaling attributes of abaloparatide with the fluorescent properties of FITC, enabling precise detection and visualization in various biochemical and cellular contexts. The FITC label allows for direct tracking of peptide localization, binding events, and internalization in vitro, making the compound a valuable tool for advanced peptide research and receptor pharmacology. Its unique structure supports a range of applications where both biological activity and fluorescence-based detection are required, facilitating mechanistic studies in peptide-receptor interactions and cellular signaling pathways.

Receptor binding assays: The FITC-abaloparatide conjugate is widely utilized in receptor binding studies to quantitatively and qualitatively assess the interaction between peptide ligands and the parathyroid hormone 1 receptor (PTH1R) or related targets. By employing fluorescence-based detection, researchers can monitor real-time binding kinetics, affinity, and specificity of the peptide to its receptor on living cells or membrane preparations. This enables high-throughput screening of receptor modulators, competitive binding experiments, and detailed mapping of ligand-receptor engagement, which are essential for elucidating signaling mechanisms and guiding the development of novel peptide analogs.

Cellular uptake and trafficking studies: The fluorescent labeling of abaloparatide with FITC provides a robust platform for investigating cellular internalization and trafficking pathways of peptide ligands. Using techniques such as flow cytometry or confocal microscopy, scientists can visualize and quantify the uptake of the peptide into target cells, track its intracellular localization, and analyze the fate of the peptide-receptor complex. These studies are critical for understanding receptor-mediated endocytosis, downstream signaling cascades, and the intracellular dynamics of peptide-based ligands.

Peptide pharmacology and structure-activity relationship (SAR) research: FITC-abaloparatide serves as a functional probe in the evaluation of the pharmacological properties of abaloparatide analogs and derivatives. By comparing the binding and signaling profiles of FITC-conjugated and unconjugated peptides, researchers can assess the impact of structural modifications on receptor interaction and biological activity. This facilitates the rational design of improved peptide therapeutics and the identification of key structural determinants governing ligand efficacy and selectivity.

Live cell imaging: The inherent fluorescence of the FITC moiety enables real-time visualization of peptide localization and receptor engagement in live cell systems. By applying advanced imaging modalities, such as confocal or total internal reflection fluorescence (TIRF) microscopy, investigators can monitor dynamic processes including ligand binding, receptor clustering, and signal transduction events at the single-cell level. This capability supports detailed mechanistic studies of peptide-receptor interactions in physiologically relevant environments.

Assay development and optimization: FITC-abaloparatide is frequently employed as a reference standard or tracer in the development of fluorescence-based assays for high-throughput screening or quantitative analysis. Its well-characterized fluorescence properties make it suitable for establishing assay sensitivity, dynamic range, and reproducibility in ligand binding or competition assays. By providing a reliable and quantifiable signal, the conjugate streamlines assay validation and facilitates the discovery of novel modulators of peptide-receptor interactions.

Source#
Synthetic
Shipping Condition
Room temperature

Useful Tools

Peptide Calculator

Abbreviation List

Peptide Glossary

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.

Featured Services
Peptide CDMOEpitope Mapping ServicescGMP Peptide ServicePeptide Analysis ServicesPeptide Nucleic Acids SynthesisPeptide Modification ServicesCustom Conjugation ServicePeptide Synthesis Services
Hot Products
About us

Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.

From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.

Our Customers